Form 4: Inari Medical CEO Andrew Hykes Reports Changes in Beneficial Ownership

Andrew Hykes, CEO of Inari Medical, reports the disposal of shares to cover tax obligations related to vesting restricted share units.

Summary

• On April 1, 2024, Andrew Hykes, the President and CEO of Inari Medical, Inc., disposed of shares of common stock to satisfy tax obligations related to the vesting of restricted share units.
• The transactions involved the disposal of 508 shares related to 2021 vesting, 947 shares related to 2022 vesting, 1,475 shares related to 2023 vesting, and 1,292 shares related to 2024 vesting.
• Following these transactions, Hykes directly owns 468,474 shares of Inari Medical common stock.
• He also indirectly owns 1,550 shares through Child 1, 1,550 shares through Child 2, 1,550 shares through Child 3, and 1,000 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions for tax purposes, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the company's outlook or strategy.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to tax obligations and do not indicate a change in the executive's confidence in the company.

Key Dates